How is CHADS-VASc score calculated for a patient with atrial fibrillation, hypertension, and diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CHA₂DS₂-VASc Score Calculation

For this 72-year-old woman with atrial fibrillation, hypertension, and diabetes, the CHA₂DS₂-VASc score is 4 points, placing her at high risk for stroke with an annual thromboembolic event rate of approximately 4.0%, warranting oral anticoagulation therapy. 1

Step-by-Step Score Calculation

The CHA₂DS₂-VASc scoring system assigns points for specific risk factors 1:

Points Awarded for This Patient:

  • C (Congestive Heart Failure): 0 points - not mentioned 1
  • H (Hypertension): 1 point - patient has hypertension 1
  • A₂ (Age ≥75 years): 0 points - patient is 72 years old (does not meet ≥75 threshold) 1
  • D (Diabetes mellitus): 1 point - patient has diabetes 1
  • S₂ (Prior Stroke/TIA/Thromboembolism): 0 points - not mentioned 1
  • V (Vascular disease): 0 points - no history of MI, PAD, or aortic plaque mentioned 1
  • A (Age 65-74 years): 1 point - patient is 72 years old 1
  • Sc (Sex category - female): 1 point - patient is female 1

Total Score: 4 points

Risk Stratification and Clinical Implications

Annual Stroke Risk

  • A CHA₂DS₂-VASc score of 4 corresponds to an adjusted annual stroke rate of 4.0% 1
  • The 2024 ESC guidelines now recommend using CHA₂DS₂-VA (removing the sex criterion), which would give this patient a score of 3, still indicating high risk 1

Treatment Recommendation

Oral anticoagulation is definitively recommended for this patient 1:

  • The 2024 ACC/AHA/HRS guidelines recommend oral anticoagulation for patients with CHA₂DS₂-VASc scores ≥2 1
  • The 2024 ESC guidelines recommend oral anticoagulation for CHA₂DS₂-VA scores ≥2, and should be considered for scores of 1 1
  • Direct oral anticoagulants (DOACs) are preferred over warfarin in eligible patients 1

Important Clinical Considerations

Common Pitfalls to Avoid:

  • Age scoring: Note that age is scored in two separate categories - 1 point for 65-74 years AND 2 additional points if ≥75 years (not cumulative, but separate thresholds) 1
  • Female sex scoring: Women receive 1 point for sex alone, meaning the minimum possible score for any woman is 1 (women cannot achieve a score of 0) 1
  • Vascular disease definition: This specifically includes prior MI, peripheral artery disease, or aortic plaque - not just any cardiovascular condition 1

Bleeding Risk Assessment:

  • While this patient requires anticoagulation based on stroke risk, concurrent assessment using HAS-BLED score is recommended to identify modifiable bleeding risk factors 1
  • A HAS-BLED score ≥3 suggests caution and need for regular review, but should not preclude anticoagulation in the absence of absolute contraindications 1, 2

Evolving Guidelines:

  • The 2024 ESC guidelines have moved toward CHA₂DS₂-VA (removing sex as a criterion), recognizing that female sex alone may not independently increase stroke risk in younger women without other risk factors 1
  • However, for this 72-year-old patient with multiple risk factors, the treatment recommendation remains unchanged regardless of which scoring system is used 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Assessment and Management of Stroke Risk in Atrial Fibrillation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is hypertension considered in calculating the CHAD VASc score if the patient has a history of hypertension or is currently being treated for it?
What is the purpose and calculation of the CHA2DS2-VASc (Congestive heart failure, Hypertension, Age, Diabetes, Vascular disease, and female Sex) score in assessing stroke risk in patients with non-rheumatic atrial fibrillation?
What is the CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) score for a 72-year-old female with a history of Ethanol (ETOH) abuse?
What is the initial CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥ 75, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74, Sex category) score for a 73-year-old male with new onset atrial fibrillation (AFib) and no known medical history?
Can the CHADS(Vascular) VASc score be used in valvular atrial fibrillation?
What is the approach to evaluating and managing elevated liver enzymes?
What does occlusion of the left external iliac artery with reconstitution of the left common femoral artery by the left inferior epigastric artery mean?
Is a patient with end-stage renal disease (ESRD) on hemodialysis (HD) who has been heavily transfused a candidate for transplant?
Is a urine output of 104oz in 24 hours acceptable for a patient on 40mg Torsemide and 100mg Spironolactone?
What is the significance of elevated ferritin (iron storage protein) levels with normal iron levels?
Can paracetamol (acetaminophen) be given to a patient with thrombocytopenia (low platelet count)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.